Nucleus Capital Research
Investment Thesis
Nucleus Capital describes itself as "First Believers in Frontier Founders": a first-check investor backing technical teams at the earliest stage. The firm is thesis-driven and high conviction, runs a concentrated portfolio, and is active in Europe and the US. It argues that the SaaS playbook does not apply to deep tech, so its support model is built for scientific ventures and tuned to the pace, complexity and capital needs of frontier innovation. It says it brings techno-economic depth, industrial networks and operational experience beyond capital, and that founders work only with decision-makers.
Sector Focus
Nucleus invests across three themes that it states on its homepage:
- Programmable Biology: where computation meets biology, including discovery tools and systems that produce at scale (Apoha, Biomia, Concert Bio, Cultzyme, Endolith, Ruby Bio, Trilobio, Magmatic, Metabologic).
- Food Technology: agriculture, food production and distribution for a more resilient food system (AtmoCooling, Bindbridge, Biographica, DAF, Juicy Marbles, Koppie, Root Global, Triple Bio).
- Neo Industrials: energy, manufacturing, materials and supply chains redesigned for a resource-constrained world (Atmio, Batch Robotics, Brineworks, Infyos, Magnify, Quint Computing, Repath, Spark E-Fuels, Telura, Ucaneo).
Stage Focus and Check Size
The firm engages at the earliest stage, before momentum is visible. Its site says checks are up to EUR 1.0M and that it leads or co-leads as the first believers. No later-stage focus is stated. Stage evidence for individual portfolio companies was not found on the pages read, so none is recorded per company.
Lead Tendency
Nucleus states that it leads or co-leads its first checks. Lead tendency is recorded as "leads" with moderate confidence, from the firm's own wording.
Recent Activity and Funds
The site links two fund investor portals, NC-I and NC-II, and a Fund II key information document, so the firm is on at least its second fund. The footer shows support from the European Investment Fund, the European Commission, Rentenbank and KfW Capital, which are institutional backers. Fund size, vintage and deployment status were not stated on the pages read, so fund status is recorded as unknown. A newsroom page exists at nucleus-capital.com/resources-and-news but was not read for dated events, so no activity events are submitted.
Portfolio Highlights
The portfolio page lists about 40 companies across four pages, three of them tagged as previous investments (Hoxton Farms, One.five, Vosbor). The homepage spotlights Apoha (London, a sensory processor called Liquid Brain), Endolith (Denver, bioleaching for copper mining), Planet A Foods (Munich, cocoa-free chocolate) and Yuri (Meckenbeuren, space-based bioreactors). Testimonials come from founders at Planet A Foods, Cultzyme, Ruby Bio and Spark E-Fuels. The firm reports that 83% of portfolio founders have a technical background, 51% of portfolio companies have a female co-founder and 43% of founders are second-time entrepreneurs.
Team
- Dr. Isabella Fandrych, General Partner (Neo Industrials and corporate relationships; industrial engineer)
- Maximilian Schwarz, General Partner (Food Tech and Programmable Biology; business background)
- Dr. Carolina Villa, Principal (Programmable Biology; bioprocess engineer, techno-economic analysis and scale-up)
- Deni Nurkic, Investment Manager (physics and deeptech company building)
- Aaron Suri, Investment Team
- Venture Partners: Raffael Wohlgensinger, Martin Weber
- Scientific advisors: Dr. Patricia Bubner, Dr. Mazen Rizk, Prof. Ian Marison
- Industry advisors: Christian Ohlshausen, Andreas Berger, Kamel Chida
- Marc Penkala (VC Advisor), Dominik Zalewski (Finance Advisor), Daniel Caspar (Head of Finance)
Decision Process
Two General Partners and a small investment team run the firm, and the site says founders only work with decision-makers. The exact process (partnership versus committee) is not stated, so it is recorded as partnership with low confidence.
Founder Preferences
Nucleus backs technical, science-led founding teams. The portfolio statistics point to a strong preference for technical founders with a high share of repeat entrepreneurs. It is a hands-on investor that describes itself as direct, open, pragmatic and personal, and says it invests selectively and stays close.
Geographic Focus
Europe and the US. The portfolio spans Germany, the UK, Switzerland, the US (Denver) and other European locations. Headquarters location and AUM were not stated on the pages read and are left unset.